Demonstration of Functional Neuronal β3-Adrenoceptors Within the Enteric Nervous System

Gastroenterology

Volumn 133, Issue 1, 2007, Pages 175-183

  Cellek, Selim ^a   Thangiah, Ramkumar ^b   Bassil, Anna K ^a   Campbell, Colin A ^a   Gray, Karen M ^a   Stretton, Jennifer L ^a   Lalude, Olutunde ^b   Vivekanandan, Shanmugam ^b   Wheeldon, Alan ^a   Winchester, Wendy J ^a   Sanger, Gareth J ^a   Schemann, Michael ^c   Lee, Kevin ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b PRINCESS ALEXANDRA HOSPITAL   (United Kingdom)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; CARBACHOL; SOMATOSTATIN;

ANALGESIA; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CHOLINERGIC NERVE CELL; COLON; DIARRHEA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE INNERVATION; MUSCLE CONTRACTION; MYENTERIC PLEXUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATOSTATIN RELEASE; VISCERAL PAIN;

EID: 34447109450     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.05.009     Document Type: Article

References (21)

1. Tan S., and Curtis-Prior P.B. Characterization of the β-adrenoceptor of the adipose cell of the rat. Int J Obes 7 (1983) 409-414
2. Berkowitz D.E., Nardone N.A., Smiley R.M., Price D.T., Kreutter D.K., Fremeau R.T., and Schwinn D.A. Distribution of β-3-adrenoceptor mRNA in human tissues. Eur J Pharmacol 289 (1995) 223-228
3. Roberts S.J., Papaioannou M., Evans B.A., and Summers R.J. Functional and molecular evidence for β 1-, β 2- and β 3- adrenoceptors in human colon. Br J Pharmacol 120 (1997) 1527-1535
4. Anthony A., Schepelmann S., Guillaume J.L., Strosberg A.D., Dhillon A.P., Pounder R.E., and Wakefield A.J. Localization of the β(β)3-adrenoceptor in the human gastrointestinal tract: an immunohistochemical study. Aliment Pharmacol Ther 12 (1998) 519-525
5. Chamberlain P.D., Jennings K.H., Paul F., Cordell J., Berry A., Holmes S.D., Park J., Chambers J., Sennitt M.V., Stock M.J., Cawthorne M.A., Young P.W., and Murphy G.J. The tissue distribution of the human β3-adrenoceptor studied using a monoclonal antibody: direct evidence of the β3-adrenoceptor in human adipose tissue, atrium and skeletal muscle. Int J Obes Relat Metab Disord 23 (1999) 1057-1065
6. Bardou M., Dousset B., Deneux-Tharaux C., Smadja C., Naline E., Chaput J.C., Naveau S., Manara L., Croci T., and Advenier C. In vitro inhibition of human colonic motility with SR 59119A and SR 59104A: evidence of a β3-adrenoceptor-mediated effect. Eur J Pharmacol 353 (1998) 281-287
7. de Ponti F., Gibelli G., Croci T., Arcidiaco M., Crema F., and Manara L. Functional evidence of atypical β 3-adrenoceptors in the human colon using the β 3-selective adrenoceptor antagonist, SR 59230A. Br J Pharmacol 117 (1996) 1374-1376
8. de Ponti F., Modini C., Gibelli G., Crema F., and Frigo G. Atypical β-adrenoceptors mediating relaxation in the human colon: functional evidence for β3 rather than β4 adrenoceptors. Pharmacol Res 39 (1999) 345-348
9. Manara L., Croci T., Aureggi G., Guagnini F., Maffrand J.P., Le Fur G., Mukenge S., and Ferla G. Functional assessment of β adrenoceptor subtypes in human colonic circular and longitudinal (taenia coli) smooth muscle. Gut 47 (2000) 337-342
10. Taborsky Jr. G.J., and Ensinck J.W. Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog. J Clin Invest 73 (1984) 216-223
11. Levasseur S., Bado A., Laigneau J.P., Moizo L., Reyl-Desmars F., and Lewin M.J. Characterization of a β 3-adrenoceptor stimulating gastrin and somatostatin secretions in rat antrum. Am J Physiol 272 (1997) G1000-G1006
12. Hasler W.L., Soudah H.C., and Owyang C. Somatostatin analog inhibits afferent response to rectal distention in diarrhea-predominant irritable bowel patients. J Pharmacol Exp Ther 268 (1994) 1206-1211
13. Croci T., Landi M., Emonds-Alt X., Le Fur G., Maffrand J.P., and Manara L. Role of tachykinins in castor oil diarrhoea in rats. Br J Pharmacol 121 (1997) 375-380
14. Boyce S, Combe R, Wheeldon A, Rupniak NM, Hill RG. Antinociceptive activity of the NMDA NR2B receptor subtype selective antagonist CP101606 in a new rat visceral pain assay. P118. International Association for the Study of Pain. 10th World Congress on Pain, 2002.
15. Uehling D.E., Shearer B.G., Donaldson K.H., Chao E.Y., Deaton D.N., Adkison K.K., Brown K.K., Cariello N.F., Faison W.L., Lancaster M.E., Lin J., Hart R., Milliken T.O., Paulik M.A., Sherman B.W., Sugg E.E., and Cowan C. Biarylaniline phenethanolamines as potent and selective β-3 adrenergic receptor agonists. J Med Chem 49 (2006) 2758-2771
16. Keast J.R., Furness J.B., and Costa M. Somatostatin in human enteric nerves. Distribution and characterization. Cell Tissue Res 237 (1984) 299-308
17. Bass R.T., Buckwalter B.L., Patel B.P., Pausch M.H., Price L.A., Strnad J., and Hadcock J.R. Identification and characterization of novel somatostatin antagonists. Mol Pharmacol 50 (1996) 709-715
18. Kobayashi S., Ikeda K., Suzuki M., Yamada T., and Miyata K. Effects of YM905, a novel muscarinic M3-receptor antagonist, on experimental models of bowel dysfunction in vivo. Jpn J Pharmacol 86 (2001) 281-288
19. Yamamoto O., Niida H., Tajima K., Tanaka M., Makita Y., Ueda F., and Yano J. Effect of α-2 adrenoceptor antagonists on colonic function in rats. Neurogastroenterol Motil 12 (2000) 249-255
20. McKeen E.S., Feniuk W., and Humphrey P.P. Somatostatin receptors mediating inhibition of basal and stimulated electrogenic ion transport in rat isolated distal colonic mucosa. Naunyn Schmiedebergs Arch Pharmacol 352 (1995) 402-411
21. Cohen M.L., Bloomquist W., Kriauciunas A., Shuker A., and Calligaro D. Aryl propanolamines: comparison of activity at human β3 receptors, rat β3 receptors, and rat atrial receptors mediating tachycardia. Br J Pharmacol 126 (1999) 1018-1024